By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nanobiotix 



Paris      France
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Nanobiotix Provides Update On Global Development Of Lead Product NBTXR3 11/28/2016 12:15:15 PM
Nanobiotix Revenue For Q3 2016 11/16/2016 10:40:01 AM
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage As In Situ Vaccine For Cancer At The Society For Immunotherapy Of Cancer Annual Meeting 11/15/2016 9:05:51 AM
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage As In Situ Vaccine For Cancer At The Society For Immunotherapy Of Cancer Annual Meeting 11/14/2016 10:16:46 AM
Nanobiotix Announces Submission For First Market Approval Of Lead Product NBTXR3 In Europe 9/14/2016 8:04:38 AM
Nanobiotix Half Year Results for the Six Months Ended 30 June 2016 8/31/2016 2:12:37 PM
Nanobiotix Revenue For Q2 2016 7/15/2016 9:22:27 AM
Nanobiotix Reports Successful Results From Phase I/II Trial Of NBTXR3 In Head & Neck Cancer 7/7/2016 8:36:11 AM
Nanobiotix Receives U.S. $1 Million Milestone Payment From PharmaEngine, Inc. 6/1/2016 8:53:13 AM
Nanobiotix Establishes Promising Preclinical Proof-Of-Concept In Immuno Oncology 5/31/2016 10:32:59 AM
123456
//-->